Latest TMDI reports update at 2023-08-19: 202020192018
Titan Medical  logo
Titan Medical TMDI
$ 0.14 -26.32%

Titan Medical Financial Statements 2011-2024 | TMDI

Annual Financial Statements Titan Medical

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

- 115 M 15.3 M 20.3 M 71.1 M 57.2 M 95.9 M 136 M 110 M 79.6 M 82.5 M

Shares

- 67 M 30.7 M 16.6 M 7.9 M 4.88 M 3.48 M 3.14 M 2.34 M 2.14 M 1.81 M

Historical Prices

0.63 1.71 0.5 1.22 9 7.2 22.5 36 26.1 36.6 39.6

Net Income

-14.9 M -24.2 M -41.9 M -22.6 M -33.6 M -23.3 M -41.4 M -13.5 M -9.07 M -7.76 M -15.8 M

Revenue

20.1 M 20 M - - - - - - - - -

Cost of Revenue

- - - - - - - - - - -

Gross Profit

- - - - - - - - - - -

Operating Income

-31 M 4.15 M -59.3 M - - - - - - - -

Interest Expense

- 1.09 M 423 K - - - - - - - -

EBITDA

-31 M 4.15 M -59.3 M - - -27.8 M -42.6 M -14.8 M -8.83 M -7.72 M -15.8 M

Operating Expenses

- - 59.3 M 39.7 M 18.9 M 27.5 M 41.8 M 14.2 M 8.83 M 7.88 M -

General and Administrative Expenses

12.4 M 7.49 M 7.81 M 6.8 M 5.97 M 4.93 M 3.53 M 3.5 M 3.48 M 3.08 M 3.07 M

All numbers in USD currency

Quarterly Income Statement Titan Medical

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

- - - - - - - - - 80.5 M 60.8 M - - 32 M 31.2 M - - 18.3 M 13.8 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

- - - -9.22 M - -8.56 M -940 K -14.8 M - -1.64 M -1.14 M -768 K - -14.5 M -14.5 M - - 7.53 M 5.89 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- - - - - - 10 M 50 K - - 10 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

- - - -12.1 M - -14.1 M -2.02 M -11.8 M - -4.52 M 7.46 M -1.73 M - -18.5 M -21.2 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- - - - - - - - - 592 K 253 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - - -12.1 M - -14.1 M -2.02 M -11.8 M - -4.52 M 7.46 M -1.73 M - -18.5 M -21.2 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

- - - 2.53 M - 3.38 M 4.84 M 4.07 M - 2.22 M 2.39 M 1.67 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency